These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 25991488)

  • 1. The diagnostic efficacy of quantitative liver MR imaging with diffusion-weighted, SWI, and hepato-specific contrast-enhanced sequences in staging liver fibrosis--a multiparametric approach.
    Feier D; Balassy C; Bastati N; Fragner R; Wrba F; Ba-Ssalamah A
    Eur Radiol; 2016 Feb; 26(2):539-46. PubMed ID: 25991488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of high-stage liver fibrosis using ADC value on diffusion-weighted imaging and quantitative enhancement ratio at the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI at 1.5 T.
    Harada TL; Saito K; Araki Y; Matsubayashi J; Nagao T; Sugimoto K; Tokuuye K
    Acta Radiol; 2018 May; 59(5):509-516. PubMed ID: 28853292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective comparison of diffusion-weighted MRI and dynamic Gd-EOB-DTPA-enhanced MRI for detection and staging of hepatic fibrosis in primary sclerosing cholangitis.
    Keller S; Sedlacik J; Schuler T; Buchert R; Avanesov M; Zenouzi R; Lohse AW; Kooijman H; Fiehler J; Schramm C; Yamamura J
    Eur Radiol; 2019 Feb; 29(2):818-828. PubMed ID: 30014204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effect of region-of-interest methods using gadoxetic acid-enhanced MR imaging with diffusion-weighted imaging on staging hepatic fibrosis.
    Ding Y; Rao S; Yang L; Chen C; Zeng M
    Radiol Med; 2016 Nov; 121(11):821-827. PubMed ID: 27449761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive assessment of hepatic fibrosis using gadoxetate-disodium-enhanced 3T MRI.
    Jang YJ; Cho SH; Bae JH; Kim GC; Ryeom H; Kim HJ; Shin KM; Lee HJ
    Ann Hepatol; 2013; 12(6):926-34. PubMed ID: 24114823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver fibrosis staging using T1 mapping on gadoxetic acid-enhanced MRI compared with DW imaging.
    Ding Y; Rao SX; Zhu T; Chen CZ; Li RC; Zeng MS
    Clin Radiol; 2015 Oct; 70(10):1096-103. PubMed ID: 26164421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staging liver fibrosis by using liver-enhancement ratio of gadoxetic acid-enhanced MR imaging: comparison with aspartate aminotransferase-to-platelet ratio index.
    Motosugi U; Ichikawa T; Oguri M; Sano K; Sou H; Muhi A; Matsuda M; Fujii H; Enomoto N; Araki T
    Magn Reson Imaging; 2011 Oct; 29(8):1047-52. PubMed ID: 21775085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative assessment of hepatic fibrosis in chronic hepatitis B and C: T1 mapping on Gd-EOB-DTPA-enhanced liver magnetic resonance imaging.
    Pan S; Wang XQ; Guo QY
    World J Gastroenterol; 2018 May; 24(18):2024-2035. PubMed ID: 29760545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of Texture Analysis on Gadoxetic Acid-enhanced MR for Detecting Liver Fibrosis in a Rat Model.
    Xu J; Wang X; Jin ZY; You Y; Wang Q; Wang ST; Xue HD
    Chin Med Sci J; 2019 Mar; 34(1):24-32. PubMed ID: 30961777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver fibrosis: histopathologic and biochemical influences on diagnostic efficacy of hepatobiliary contrast-enhanced MR imaging in staging.
    Feier D; Balassy C; Bastati N; Stift J; Badea R; Ba-Ssalamah A
    Radiology; 2013 Nov; 269(2):460-8. PubMed ID: 23878281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver Fibrosis: Deep Convolutional Neural Network for Staging by Using Gadoxetic Acid-enhanced Hepatobiliary Phase MR Images.
    Yasaka K; Akai H; Kunimatsu A; Abe O; Kiryu S
    Radiology; 2018 Apr; 287(1):146-155. PubMed ID: 29239710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion-weighted MRI-based Virtual Elastography for the Assessment of Liver Fibrosis.
    Kromrey ML; Le Bihan D; Ichikawa S; Motosugi U
    Radiology; 2020 Apr; 295(1):127-135. PubMed ID: 32043948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH; Kim SH; Park MJ; Park CK; Rhim H
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion kurtosis imaging with the breath-hold technique for staging hepatic fibrosis: A preliminary study.
    Yoshimaru D; Miyati T; Suzuki Y; Hamada Y; Mogi N; Funaki A; Tabata A; Masunaga A; Shimada M; Tobari M; Nishino T
    Magn Reson Imaging; 2018 Apr; 47():33-38. PubMed ID: 29158186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staging liver fibrosis on multiparametric MRI in a rabbit model with elastography, susceptibility-weighted imaging and T1ρ imaging: a preliminary study.
    Zou LQ; Zhao F; Zhang H; Zhang K; Xing W
    Acta Radiol; 2021 Feb; 62(2):155-163. PubMed ID: 32326722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of liver fibrosis with gadoxetic acid-enhanced MRI: comparisons with transient elastography, ElastPQ, and serologic fibrosis markers.
    Jang HJ; Min JH; Lee JE; Shin KS; Kim KH; Choi SY
    Abdom Radiol (NY); 2019 Aug; 44(8):2769-2780. PubMed ID: 31041497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis.
    Sandrasegaran K; Akisik FM; Lin C; Tahir B; Rajan J; Saxena R; Aisen AM
    AJR Am J Roentgenol; 2009 Dec; 193(6):1556-60. PubMed ID: 19933647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gd-EOB-DTPA-enhanced MR imaging: prediction of hepatic fibrosis stages using liver contrast enhancement index and liver-to-spleen volumetric ratio.
    Goshima S; Kanematsu M; Watanabe H; Kondo H; Kawada H; Moriyama N; Bae KT
    J Magn Reson Imaging; 2012 Nov; 36(5):1148-53. PubMed ID: 22848019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging--preliminary observations.
    Watanabe H; Kanematsu M; Goshima S; Kondo H; Onozuka M; Moriyama N; Bae KT
    Radiology; 2011 Apr; 259(1):142-50. PubMed ID: 21248234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of liver fibrosis in rats by MRI with apparent diffusion coefficient and T1 relaxation time in the rotating frame.
    Hu G; Zhang X; Liang W; Zhong X; Chan Q; Lin X; Lin T; Li Y; Quan X
    J Magn Reson Imaging; 2016 May; 43(5):1082-9. PubMed ID: 26497954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.